Best of ASCO Review. Earn up to 3.75 AMA PRA Category 1 Credits

Transcription

1 Presents Best of ASCO Review Earn up to 3.75 AMA PRA Category 1 Credits Saturday, September 15, :00 a.m. 12:15 p.m. OU Andrews Academic Tower 800 Stanton L. Young Blvd. Oklahoma City, OK 1st Floor Conference Rooms A, B, and C Register Online: OUHSC.CLOUD-CME.Com

2 Accredita on Statement: This ac vity has been planned and implemented in accordance with the accredita on requirements and policies of the Accredita on Council for Con nuing Medical Educa on (ACCME) through the joint providership of the University of Oklahoma College of Medicine and the Oklahoma Society of Clinical Oncology, Inc. The University of Oklahoma College of Medicine is accredited by the ACCME to provide con nuing medical educa on for physicians. The University of Oklahoma College of Medicine designates this live ac vity for a maximum of 3.75 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their par cipa on in the ac vity. Conflict Resolu on Statement: The University of Oklahoma College of Medicine, Office of Con nuing Professional Development has reviewed this ac vity s speaker and planner disclosures and resolved all iden fied conflicts of interest, if applicable. Ac vity Descrip on: The OSCO Best of ASCO Review will highlight the foremost research and strategies in oncology that were presented at the 2018 ASCO Annual Mee ng. Topics will include Neo and Post op Adjuvant Therapy in Pancrea c Cancer, Advances in Combina on Immunotherapies for Melanoma, Results of TAILORx (Trial Assigning Individualized Op ons for Treatment) and Advances in Lung Cancer. Intended/Target Audience: Hematologists and Oncologists, Nurses, Pharmacists, Physician Assistants and other health care professionals specializing in Oncology. Overall Learning Objec ves: Upon comple on of this ac vity, par cipants will improve their competence and performance by being able to: 1. Discuss the latest advances in combina on immunotherapies for Melanoma. 2. Explain the TAILORx Results (Trial Assigning Individualized Op ons for Treatment). 3. Discuss FOLFIRINOX Neo and Post op Adjuvant Therapy in Pancrea c Cancer. 4. Iden fy the latest advances in lung cancer treatment. Planning Commi ee Members: William C. Dooley, MD, FACS, Course Director Jose Eugenio Najera, MD Mary K. Lindemuth, MD, PGY 4, Surgery Resident Kathy Musson Course Contact Doctors Dooley and Lindemuth will share moderator responsibilities throughout the course.

3 Nondiscrimina on Statement: The University of Oklahoma, in compliance with all applicable federal and state laws and regula ons, does not discriminate on the basis of race, color, na onal origin, sex, sexual orienta on, gene c informa on, gender iden ty, gender expression, age, religion, disability, poli cal beliefs, or status as a veteran in any of its policies, prac ces or procedures. This includes, but is not limited to: admissions, employment, financial aid and educa onal services. Inquiries regarding non discrimina on policies may be directed to: Bobby J. Mason, Ins tu onal Equity Officer, (405) , bjm@ou.edu, or visit Accommoda on Statement: Accommoda ons on the basis of disability are available by contac ng Kathy Musson by phone at (405) or by e mail to kmussonokc@gmail.com as soon as possible. Acknowledgement of Commercial and In Kind Support: Commercial support is financial, or in kind, contribu ons given by a commercial interest, which is used to pay all or part of the costs of a CME ac vity. A commercial interest is any en ty producing, marke ng, re selling, or distribu ng health care goods or services consumed by, or used on, pa ents. Appropriate acknowledgement of all commercial and in kind support will be given at the me of the educa onal ac vity. Disclaimer Statement: Statements, opinions and results of studies contained in the program are those of the presenters, authors and joint provider and do not reflect the policy or posi on of the Board of Regents of the University of Oklahoma ( OU ) nor does OU provide any warranty as to their accuracy or reliability. Every reasonable effort has been made to faithfully reproduce the presenta ons and material as submi ed. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or opera on of any methods, products, instruments or ideas contained in the material herein. Policy on Faculty, Joint Provider and Presenters Disclosure: It is the policy of the University of Oklahoma, College of Medicine that the faculty, presenters and joint provider disclose real or apparent conflicts of interest rela ng to the topics of this educa onal ac vity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presenta on(s). Further Informa on is available by contac ng Kathy Musson, Execu ve Director of the Oklahoma Society of Clinical Oncology, Inc. by e mail at kmussonokc@gmail.com or by phone at (405) Accredita on Council for Graduate Medical Educa on (ACGME): American Board of Medical Special es (ABMS) Competencies: Pa ent Care Medical Knowledge

4 Registra on Fee: Register at Registration Fee: Physicians $75 Other Health Care Professionals $25 Registration for this year s conference will be online through the OU College of Medicine, Office of Continuing Professional Development website. Please visit the website for instructions on how to sign in and register for the conference. Parking informa on for a endees of the OSCO Best of ASCO Review Andrews Academic Tower Conference Center, Entrance off Stanton L. Young Blvd Visitor/Events Parking available in Lot 11F. Gate code available upon request. OUHSC residents and staff are to park in their normal parking areas. Speaker Informa on Geoffrey T. Gibney, MD Co-Leader Melanoma Disease Group at Lombardi Comprehensive Cancer Center and Medstar Georgetown University Hospital Stephanie Graff, MD, Sarah Cannon Cancer Ins tute HCA Midwest Health Hedy Lee Kindler, MD, FASCO Speaker Pending Professor of Medicine, University of Chicago Medicine

5 Presents the Best of ASCO Review Saturday, September 15, 2018 Andrews Academic Tower 800 Stanton L. Young Blvd. Oklahoma City, Oklahoma Conference Rooms A, B, and C Moderators: William C. Dooley, MD, FACS and Mary K. Lindemuth, MD, PGY 4, Surgery Resident 7:00 am Exhibitor Setup 7:15 8:00 am Registra on & Con nental Breakfast 8:00 8:15 am Introduc ons/announcements 8:15 8:55 am We re FINALLY Making Progress in Pancrea c Cancer: Updates from ASCO Hedy Lee Kindler, MD, FASCO University of Chicago Medicine 8:55 9:05 am Q&A 9:05 9:45 am Combina on Immunotherapy Strategies in Melanoma and Other Malignancies Current State and Future Direc ons Geoffrey T. Gibney, MD Georgetown University 9:45 9:55 am Q&A 9:55 10:15 am Break for exhibits/refreshments 10:15 10:55 am TAILORx and the Modern Landscape of Gene Expression in Early Stage Breast Cancer Stephanie Graff, MD Sarah Cannon Cancer Ins tute HCA Midwest Health 10:55 11:05 am Q&A 11:05 11:45 am Advances in Lung Cancer Speaker pending 11:45 am 12:15 pm Ques ons & Answers with Whole Panel 12:15 pm Adjourn

6 The (OSCO) serves as the hub for oncology-related news and advances in Oklahoma. Our organization is made up of clinics and healthcare professionals working together to safeguard the rights of patients and to maintain high medical and ethical standards in the industry. OSCO Charter Advance the sciences of hematology and oncology and its sub-specialties and improve services to the public by studying the socio-economic aspects of the practice of its members. Encourage improved educational opportunities for members. Promote interchange between members. Safeguard the rights of patients with neoplastic diseases. Define the qualifications of physicians practicing hematology and oncology in Oklahoma. Serve as spokesperson and liaison to governmental and insurance interests on behalf of its members. Disseminate information regarding legislative and regulatory developments affecting the issues of common concern to members. Promote scientific inquiry and exchange between members. Establish and maintain high medical and ethical standards for members. Promote good fellowship among its members. OSCO Board of Directors Eugenio Najera, MD, President Cancer Centers of Southwest Oklahoma Samuel Bieligk, MD, FACS, Treasurer Saint Francis Health System William C. Dooley, MD, FACS, Past-President OU Medical Center, Dept of Surgery Raid Aljumaily, MD, Board Member Todd M. Kliewer, MD, Board Member SSM Health-Saint Anthony Hospital George Selby, MD, Board Member Christina E. Henson, MD, Board Member Jordan Morton, MD, Board Member Mercy Clinic Oncology & Hematology Sanjay Patel, MD, Board Member Susanna Ulahannan, MD, Board Member Kathy Musson, CAE, Executive Director P.O. Box Oklahoma City, OK Office:

7 Best of ASCO Review CME # September 15, 2018 Andrews Academic Tower 1 st Floor Conference Rooms A, B, and C OU Health Sciences Center First Name: Middle Last Name Degree Address Specialty City State Zip Phone ( ) Fax ( ) Cell Phone (Required) Date of Birth NPI Number Emergency Contact Name Phone ( ) Please provide an address that you will be able to access. You will use this address to complete your evalua on and print your CME cer ficate. * *Please indicate whether you consent to the receipt of future promo onal electronic messages from the University of Oklahoma, College of Medicine Office of Con nuing Professional Development by marking the box in the affirma ve and by execu ng where noted below and providing us with your address. We will not share your or contact informa on with anyone outside of the CPD office. I consent to the receipt of future promo onal electronic messages from the University of Oklahoma, College of Medicine, Office of CPD I decline to receive future promo onal electronic messages from the University of Oklahoma, College of Medicine Office of CPD Registra on Type (please select one) Registra on Type Registra on Rate Physicians $75 Other Healthcare Providers $25 Residents/Students No Charge (call for online registra on instruc ons) TOTAL AMOUNT DUE: $ Payment Method: Departmental Transfer (OUHSC only) Char ield spread: MISCA COM Purchase order (please e mail a copy of the PO to jan quayle@ouhsc.edu) Check: Check Number: Credit Card: (Visa, MasterCard, or Discover) Card Number Expira on Date Total Amount Charged $ Signature Name as it appears on card (please print) MAIL WITH PAYMENT TO: OUHSC, Office of CPD PO Box 26901, AAT 4000 Oklahoma City, OK Tax ID: # For ques ons or more informa on, contact Susie Dealy: susie dealy@ouhsc.edu or , ext. 1